Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin®], enoxaparin [Lovenox®]) and factor Xa inhibitors (fondaparinux [Arixtra®]). In the last several years, global market of injectable anticoagulants developed slowly. In 2016, global revenue of injectable anticoagulants is nearly 5300 M USD. And the global growth rate is slow.
The classification of injectable anticoagulants includes LMWH, DTI and other, and the proportion of LMWH in 2016 is about 55%, and the proportion is in decreasing trend from 2012 to 2016.Injectable anticoagulants are widely used for VTE, ACS/MI, AF and other field. The most proportion of injectable anticoagulants used to treat AF, and the revenue in 2016 is 3400 M USD.
This report elaborates on the current development of the Injectable Anticoagulants industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Pfizer
Aspen
Sanofi
Otsuka
The Medicines Company
Boehringer Ingelheim
Genentech (Roche)
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Low-molecular-weight Heparin (LMWH)
Direct Thrombin Inhibitor (DTI)
Other
Application:
VTE
ACS/MI
AF
Other
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Injectable Anticoagulants Industry Overview
-
1.1.1 Injectable Anticoagulants Market Scope and Market Segments
-
1.1.2 Injectable Anticoagulants Industry Characteristics
-
1.1.3 Global and China Injectable Anticoagulants Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Injectable Anticoagulants Production Value and Growth Rate (2017-2028)
-
1.2 Global Injectable Anticoagulants Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Low-molecular-weight Heparin (LMWH)
-
1.2.2 Direct Thrombin Inhibitor (DTI)
-
1.2.3 Other
-
1.3 Global Injectable Anticoagulants Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 VTE
-
1.3.2 ACS/MI
-
1.3.3 AF
-
1.3.4 Other
-
1.4 Market Analysis by Region
-
1.4.1 North America Injectable Anticoagulants Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Injectable Anticoagulants Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Injectable Anticoagulants Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Injectable Anticoagulants Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Injectable Anticoagulants Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Injectable Anticoagulants Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Injectable Anticoagulants Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Injectable Anticoagulants Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Injectable Anticoagulants Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Injectable Anticoagulants Industry Porter's Five Forces Model Analysis
-
2.2.3 Injectable Anticoagulants Industry PEST Analysis
-
2.3 Injectable Anticoagulants Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Injectable Anticoagulants Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Injectable Anticoagulants Industry
Chapter 3 Global and China Injectable Anticoagulants Market, by Manufacturer
-
3.1 Global and China Injectable Anticoagulants Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Injectable Anticoagulants Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Injectable Anticoagulants Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Injectable Anticoagulants Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Injectable Anticoagulants Market Top 3 Players
Chapter 4 Global and China Injectable Anticoagulants Market, by Type (2017-2028)
-
4.1 Injectable Anticoagulants Market Trend, by Type
-
4.2 Global Injectable Anticoagulants Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Injectable Anticoagulants Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Injectable Anticoagulants Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Injectable Anticoagulants Price Trend, by Type (2017-2028)
-
4.3 China Injectable Anticoagulants Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Injectable Anticoagulants Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Injectable Anticoagulants Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Injectable Anticoagulants Price Trend, by Type (2017-2028)
Chapter 5 Global and China Injectable Anticoagulants Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Injectable Anticoagulants Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Injectable Anticoagulants Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Injectable Anticoagulants Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Injectable Anticoagulants Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Injectable Anticoagulants Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Injectable Anticoagulants Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Injectable Anticoagulants Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Injectable Anticoagulants Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Injectable Anticoagulants Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Injectable Anticoagulants Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Injectable Anticoagulants Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Injectable Anticoagulants Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Injectable Anticoagulants Market Analysis
-
7.1 North America Injectable Anticoagulants Market, by Type
-
7.2 North America Injectable Anticoagulants Market, by Application
-
7.3 North America Injectable Anticoagulants Market Analysis and Forecast, by Country
-
7.3.1 United States Injectable Anticoagulants Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Injectable Anticoagulants Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Injectable Anticoagulants Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Injectable Anticoagulants Market Analysis
-
8.1 Europe Injectable Anticoagulants Market, by Type
-
8.2 Europe Injectable Anticoagulants Market, by Application
-
8.3 Europe Injectable Anticoagulants Market Analysis and Forecast, by Country
-
8.3.1 Germany Injectable Anticoagulants Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Injectable Anticoagulants Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Injectable Anticoagulants Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Injectable Anticoagulants Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Injectable Anticoagulants Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Injectable Anticoagulants Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Injectable Anticoagulants Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Injectable Anticoagulants Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Injectable Anticoagulants Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Injectable Anticoagulants Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Injectable Anticoagulants Market Analysis
-
9.1 APAC Injectable Anticoagulants Market, by Type
-
9.2 APAC Injectable Anticoagulants Market, by Application
-
9.3 APAC Injectable Anticoagulants Market Analysis and Forecast, by Country
-
9.3.1 China Injectable Anticoagulants Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Injectable Anticoagulants Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Injectable Anticoagulants Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Injectable Anticoagulants Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Injectable Anticoagulants Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Injectable Anticoagulants Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Injectable Anticoagulants Market Analysis
-
10.1 Latin America, Middle East and Africa Injectable Anticoagulants Market, by Type
-
10.2 Latin America, Middle East and Africa Injectable Anticoagulants Market, by Application
-
10.3 Latin America, Middle East and Africa Injectable Anticoagulants Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Injectable Anticoagulants Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Injectable Anticoagulants Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Injectable Anticoagulants Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Injectable Anticoagulants Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Injectable Anticoagulants Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Injectable Anticoagulants Company Profiles
-
11.1 Pfizer
-
11.1.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Pfizer Injectable Anticoagulants Product Profiles, Application and Specification
-
11.1.3 Pfizer Injectable Anticoagulants Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Aspen
-
11.2.1 Aspen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Aspen Injectable Anticoagulants Product Profiles, Application and Specification
-
11.2.3 Aspen Injectable Anticoagulants Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Sanofi
-
11.3.1 Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Sanofi Injectable Anticoagulants Product Profiles, Application and Specification
-
11.3.3 Sanofi Injectable Anticoagulants Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Otsuka
-
11.4.1 Otsuka Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Otsuka Injectable Anticoagulants Product Profiles, Application and Specification
-
11.4.3 Otsuka Injectable Anticoagulants Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 The Medicines Company
-
11.5.1 The Medicines Company Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 The Medicines Company Injectable Anticoagulants Product Profiles, Application and Specification
-
11.5.3 The Medicines Company Injectable Anticoagulants Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Boehringer Ingelheim
-
11.6.1 Boehringer Ingelheim Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Boehringer Ingelheim Injectable Anticoagulants Product Profiles, Application and Specification
-
11.6.3 Boehringer Ingelheim Injectable Anticoagulants Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Genentech (Roche)
-
11.7.1 Genentech (Roche) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Genentech (Roche) Injectable Anticoagulants Product Profiles, Application and Specification
-
11.7.3 Genentech (Roche) Injectable Anticoagulants Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Injectable Anticoagulants Industry Investment Prospect and Risk Assessment
-
12.1 Injectable Anticoagulants Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Injectable Anticoagulants Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Injectable Anticoagulants Sales Volume and Growth Rate (2017-2028)
-
Figure China Injectable Anticoagulants Sales Volume and Growth Rate (2017-2028)
-
Figure Global Injectable Anticoagulants Production Value and Growth Rate (2017-2028)
-
Figure China Injectable Anticoagulants Production Value and Growth Rate (2017-2028)
-
Figure Global Injectable Anticoagulants Market Size and Growth Rate of Low-molecular-weight Heparin (LMWH) (2017-2028)
-
Figure Global Injectable Anticoagulants Market Size and Growth Rate of Direct Thrombin Inhibitor (DTI) (2017-2028)
-
Figure Global Injectable Anticoagulants Market Size and Growth Rate of Other (2017-2028)
-
Figure Global Injectable Anticoagulants Market Size and Growth Rate of VTE (2017-2028)
-
Figure Global Injectable Anticoagulants Market Size and Growth Rate of ACS/MI (2017-2028)
-
Figure Global Injectable Anticoagulants Market Size and Growth Rate of AF (2017-2028)
-
Figure Global Injectable Anticoagulants Market Size and Growth Rate of Other (2017-2028)
-
Figure North America Injectable Anticoagulants Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Injectable Anticoagulants Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Injectable Anticoagulants Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Injectable Anticoagulants Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Injectable Anticoagulants Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Injectable Anticoagulants Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Injectable Anticoagulants Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Injectable Anticoagulants Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Injectable Anticoagulants Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Injectable Anticoagulants Market Share, by Manufacturer in 2021
-
Figure Global and China Injectable Anticoagulants Market Share, by Manufacturer in 2022
-
Table Global Injectable Anticoagulants Sales Volume, by Type (2017-2028)
-
Table Global Injectable Anticoagulants Sales Volume Share, by Type (2017-2028)
-
Figure Global Injectable Anticoagulants Sales Volume Share, by Type (2017-2028)
-
Table Global Injectable Anticoagulants Sales Value, by Type (2017-2028)
-
Table Global Injectable Anticoagulants Sales Value Share, by Type (2017-2028)
-
Figure Global Injectable Anticoagulants Price Trend, by Type (2017-2028)
-
Table China Injectable Anticoagulants Sales Volume, by Type (2017-2028)
-
Table China Injectable Anticoagulants Sales Volume Share, by Type (2017-2028)
-
Figure China Injectable Anticoagulants Sales Volume Share, by Type (2017-2028)
-
Table China Injectable Anticoagulants Sales Value, by Type (2017-2028)
-
Table China Injectable Anticoagulants Sales Value Share, by Type (2017-2028)
-
Figure China Injectable Anticoagulants Price Trend, by Type (2017-2028)
-
Table Global Injectable Anticoagulants Sales Volume, by Application (2017-2028)
-
Table Global Injectable Anticoagulants Sales Volume Share, by Application (2017-2028)
-
Figure Global Injectable Anticoagulants Sales Volume Share, by Application (2017-2028)
-
Table Global Injectable Anticoagulants Sales Value, by Application (2017-2028)
-
Table Global Injectable Anticoagulants Sales Value Share, by Application (2017-2028)
-
Figure Global Injectable Anticoagulants Sales Value Share, by Application (2017-2028)
-
Table China Injectable Anticoagulants Sales Volume, by Application (2017-2028)
-
Table China Injectable Anticoagulants Sales Volume Share, by Application (2017-2028)
-
Figure China Injectable Anticoagulants Sales Volume Share, by Application (2017-2028)
-
Table China Injectable Anticoagulants Sales Value, by Application (2017-2028)
-
Table China Injectable Anticoagulants Sales Value Share, by Application (2017-2028)
-
Figure China Injectable Anticoagulants Sales Value Share, by Application (2017-2028)
-
Figure China Injectable Anticoagulants Production, Import, Consumption and Export (2017-2022)
-
Figure North America Injectable Anticoagulants Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Injectable Anticoagulants Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Injectable Anticoagulants Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Injectable Anticoagulants Production, Import, Consumption and Export (2017-2022)
-
Table North America Injectable Anticoagulants Sales Volume, by Type (2017-2028)
-
Table North America Injectable Anticoagulants Sales Volume Share, by Type (2017-2028)
-
Figure North America Injectable Anticoagulants Sales Volume Share, by Type (2017-2028)
-
Table North America Injectable Anticoagulants Sales Volume, by Application (2017-2028)
-
Table North America Injectable Anticoagulants Sales Volume Share, by Application (2017-2028)
-
Figure North America Injectable Anticoagulants Sales Volume Share, by Application (2017-2028)
-
Figure United States Injectable Anticoagulants Sales Volume and Growth Rate (2017-2028)
-
Figure United States Injectable Anticoagulants Sales Value and Growth Rate (2017-2028)
-
Figure Canada Injectable Anticoagulants Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Injectable Anticoagulants Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Injectable Anticoagulants Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Injectable Anticoagulants Sales Value and Growth Rate (2017-2028)
-
Table Europe Injectable Anticoagulants Sales Volume, by Type (2017-2028)
-
Table Europe Injectable Anticoagulants Sales Volume Share, by Type (2017-2028)
-
Figure Europe Injectable Anticoagulants Sales Volume Share, by Type (2017-2028)
-
Table Europe Injectable Anticoagulants Sales Volume, by Application (2017-2028)
-
Table Europe Injectable Anticoagulants Sales Volume Share, by Application (2017-2028)
-
Figure Europe Injectable Anticoagulants Sales Volume Share, by Application (2017-2028)
-
Figure Germany Injectable Anticoagulants Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Injectable Anticoagulants Sales Value and Growth Rate (2017-2028)
-
Figure UK Injectable Anticoagulants Sales Volume and Growth Rate (2017-2028)
-
Figure UK Injectable Anticoagulants Sales Value and Growth Rate (2017-2028)
-
Figure France Injectable Anticoagulants Sales Volume and Growth Rate (2017-2028)
-
Figure France Injectable Anticoagulants Sales Value and Growth Rate (2017-2028)
-
Figure Italy Injectable Anticoagulants Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Injectable Anticoagulants Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Injectable Anticoagulants Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Injectable Anticoagulants Sales Value and Growth Rate (2017-2028)
-
Figure Spain Injectable Anticoagulants Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Injectable Anticoagulants Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Injectable Anticoagulants Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Injectable Anticoagulants Sales Value and Growth Rate (2017-2028)
-
Figure Poland Injectable Anticoagulants Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Injectable Anticoagulants Sales Value and Growth Rate (2017-2028)
-
Figure Russia Injectable Anticoagulants Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Injectable Anticoagulants Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Injectable Anticoagulants Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Injectable Anticoagulants Sales Value and Growth Rate (2017-2028)
-
Table APAC Injectable Anticoagulants Sales Volume, by Type (2017-2028)
-
Table APAC Injectable Anticoagulants Sales Volume Share, by Type (2017-2028)
-
Figure APAC Injectable Anticoagulants Sales Volume Share, by Type (2017-2028)
-
Table APAC Injectable Anticoagulants Sales Volume, by Application (2017-2028)
-
Table APAC Injectable Anticoagulants Sales Volume Share, by Application (2017-2028)
-
Figure APAC Injectable Anticoagulants Sales Volume Share, by Application (2017-2028)
-
Figure China Injectable Anticoagulants Sales Volume and Growth Rate (2017-2028)
-
Figure China Injectable Anticoagulants Sales Value and Growth Rate (2017-2028)
-
Figure Japan Injectable Anticoagulants Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Injectable Anticoagulants Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Injectable Anticoagulants Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Injectable Anticoagulants Sales Value and Growth Rate (2017-2028)
-
Figure India Injectable Anticoagulants Sales Volume and Growth Rate (2017-2028)
-
Figure India Injectable Anticoagulants Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Injectable Anticoagulants Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Injectable Anticoagulants Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Injectable Anticoagulants Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Injectable Anticoagulants Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Injectable Anticoagulants Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Injectable Anticoagulants Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Injectable Anticoagulants Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Injectable Anticoagulants Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Injectable Anticoagulants Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Injectable Anticoagulants Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Injectable Anticoagulants Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Injectable Anticoagulants Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Injectable Anticoagulants Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Injectable Anticoagulants Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Injectable Anticoagulants Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Injectable Anticoagulants Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Injectable Anticoagulants Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Injectable Anticoagulants Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Injectable Anticoagulants Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Injectable Anticoagulants Sales Value and Growth Rate (2017-2028)
-
Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Pfizer Product Profiles, Application and Specification
-
Table Pfizer Injectable Anticoagulants Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Aspen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Aspen Product Profiles, Application and Specification
-
Table Aspen Injectable Anticoagulants Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Sanofi Product Profiles, Application and Specification
-
Table Sanofi Injectable Anticoagulants Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Otsuka Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Otsuka Product Profiles, Application and Specification
-
Table Otsuka Injectable Anticoagulants Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table The Medicines Company Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table The Medicines Company Product Profiles, Application and Specification
-
Table The Medicines Company Injectable Anticoagulants Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Boehringer Ingelheim Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Boehringer Ingelheim Product Profiles, Application and Specification
-
Table Boehringer Ingelheim Injectable Anticoagulants Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Genentech (Roche) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Genentech (Roche) Product Profiles, Application and Specification
-
Table Genentech (Roche) Injectable Anticoagulants Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
